Tenderwize
Back to tender search

Open-House-Biologika-Rabattverträge 2025-29 - Omalizumab

Techniker Krankenkasse·Hamburg, Germany·Deadline Oct 30, 2027 · 438 days left·Open·Supplies
Sign up to saveOpen documents
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2025-29 - Omalizumab

5/100

Opportunity Score

High riskLow complexity
SuppliesOpen
Why this score?

Opportunity

5 / 100

Complexity

30 / 100

Risk factors

The XML change notice states the procedure was prematurely ended on 30.06.2026. The structured data still shows a futur...

No estimated contract value or framework maximum is provided. The financial attractiveness cannot be assessed.

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Weak opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until Oct 2027
  • Conclusion of drug discount agreements for the active substance Omalizumab under German social law (§130a Abs. 8 SGB V).
  • Open House procedure: no individual negotiations, uniform conditions, no exclusivity.
Show full summary

This notice concerns an Open-House procedure (not a classic EU procurement) for discount agreements on the active substance Omalizumab, under §130a Abs. 8 SGB V. The lead buyer is Techniker Krankenkasse. The procedure was originally open until October 2027, but a change notice (XML) indicates the procedure was prematurely ended on 30 June 2026. No estimated value is provided. Only one lot exists. Eligibility requires pharmaceutical entrepreneur status with proper authorization. Award criteria are not specified (placeholder only). Documents were not analyzed. Due to the premature termination, this tender is effectively closed.

Risks

The XML change notice states the procedure was prematurely ended on 30.06.2026. The structured data still shows a futur...

No estimated contract value or framework maximum is provided. The financial attractiveness cannot be assessed.

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Must be a pharmaceutical entrepreneur as defined in §4 Abs. 18 AMG with a valid authorization for the offered medicinal product.
  • Sitz in Germany, another EU member state, or EEA state (§9 Abs. 2 Satz 1 AMG).

Eligibility

  • Declaration of eligibility and reliability (Anlage 4) to be signed in text form.

Requirements may be incomplete.

Award Criteria

Lot 1

No explicit award criteria; procedure is Open House with uniform conditions, not a competitive award.

Buyer

Location

Hamburg, DEU

Identifier

992-80116-93

Activity

Health

Lots (1)

LOT-0001

Open-House-Biologika-Rabattverträge 2025-29 - Omalizumab

Conclusion of discount agreements for Omalizumab with all eligible pharmaceutical entrepreneurs. No exclusivity, fixed conditions. Max contract duration 24 months from 01.11.2025 to 31.10.2027.

SuppliesEU fundedElectronic submission

Location

DE600, Germany

Duration

Oct 2025 - Oct 2027

Category

Pharmaceutical products

Award Criteria

No explicit award criteria; procedure is Open House with uniform conditions, not a competitive award.

Deadline

Deadline Oct 30, 2027

Procurement Details

Publication date
20 May 2026
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
347743-2026

Documents (1)

Procurement document 1

Similar tenders

Germany – Site preparation work – VE111 Baustelleneinrichtung (119VM514 / Kronsh,SanDstBw,Ersatzneub. ZInstSanBw)

Sep 15
1 SME lot

Poland – Advertising and marketing services – Zaplanowanie i realizacja kampanii Ministerstwa Finansów z zakresu działalności resortu finansów

Sep 17

France – Insurance services – Prestations de services d'assurance pour groupement le groupement hospitalier de territoire Yvelines Nord

Sep 14
6 SME lots

Finland – Architectural, construction, engineering and inspection services – Tietomallikoordinaattori-, inventointimittaus- ja mallinnuspalvelujen puitejärjestely 2026-2028 (2028-2030)

Aug 27
3 framework lots3 SME lots

Greece – Cultural event organisation services – ΛΕΙΤΟΥΡΓΙΑ ΤΟΥ ΘΕΑΤΡΟΥ ΟΛΥΜΠΙΑ ΜΑΡΙΑ ΚΑΛΛΑΣ ΜΕ ΕΞΕΙΔΙΚΕΥΜΕΝΟ ΠΡΟΣΩΠΙΚΟ

Sep 18

Spain – Architectural, construction, engineering and inspection services – Redacción del Proyecto Básico y de Ejecución, Redacción del Estudio de Seguridad y Salud y Dirección de Obra para la construcción del I.E.S. Nº 1 de 12+0 uds. (Fase 1) en la urbanización El Bosque de Pioz (Guadalajara).

Sep 24